ArticleEuropean journal of medical research2025
Longitudinal changes in estimated glucose disposal rate and risk of cardiovascular disease among adults with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aging population and medical advancements have led to a rise in chronic conditions such as metabolic syndrome, cardiovascular disease (CVD), and chronic kidney disease, giving rise to the concept of cardiovascular-kidney-metabolic (CKM) syndrome. The estimated glucose disposal rate (eGDR) is an important surrogate marker of insulin sensitivity; however, its longitudinal impact on CVD risk across CKM syndrome stages 0 to 3 remains unclear.
methodsData were derived from the China Health and Retirement Longitudinal Study (CHARLS). After excluding participants lacking CKM stage 0-3 diagnostic indicators and those with incomplete data, a total of 3,503 eligible individuals were included. eGDR was calculated based on waist circumference, hypertension status, and HbA1c level. K-means clustering was applied to classify participants into five distinct trajectories based on eGDR dynamics. Cox proportional hazards models with increasing levels of adjustment were constructed to examine the association between eGDR and incident CVD. Additionally, restricted cubic spline (RCS) and weighted quantile sum (WQS) regression analyses were conducted for further evaluation.
resultsDuring a three-year follow-up, 504 participants (14.39%) developed CVD. Compared with participants in the persistently high eGDR group (Class 1), the fully adjusted Cox models revealed significantly increased CVD risk in Class 4 (HR = 2.01; 95% CI 1.46-2.77; P < 0.001), and Class 5 (HR = 2.09; 95% CI 1.16-3.97; P < 0.05), while no significant association was observed for Class 2 and Class3. When cumulative eGDR was treated as a continuous variable, each unit increase in eGDR was associated with a 7% reduction in CVD risk (HR = 0.93; 95% CI 0.90-0.96; P < 0.001). Participants in the highest cumulative eGDR quintile exhibited a 66% lower risk of CVD compared to those in the lowest quintile in the fully adjusted model. RCS analysis showed an overall inverse relationship between cumulative eGDR and CVD risk, with a marked risk reduction when cumulative eGDR exceeded 28.5 (P for non-linearity > 0.05). WQS regression further identified waist circumference as the most influential component of eGDR in relation to CVD risk.
conclusionLower cumulative eGDR and unfavorable eGDR trajectories are significantly associated with increased CVD risk among individuals in CKM stages 0-3. These findings suggest that monitoring eGDR may enhance early CVD risk prediction and guide prevention strategies in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.